drugset / Trial / NCT06560814

Non-surgical Interventions for Infertility in Endometriosis

NCT06560814

RandomizedParallel-groupOpen-labelTreatment

Summary

A parallel design randomized clinical trial was carried out on 18 women with clinically diagnosed endometriosis who wish pregnancy in the Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, (BSMMU), Shahbag, Dhaka. Those who voluntarily provide consent to participate in this study will be randomly allocated to one of the two treatment arms. Allocation concealment will be done by sequentially numbered sealed envelopes. The arms and interventions are cabergoline (0.5 mg twice weekly for 6 months, plus timed intercourse) and dydrogesteron (20 mg daily from day 5 to day 25 of menstrual cycle for 6 months, plus timed intercourse).The women will be assessed by telephone interview at monthly intervals, TVS and serum Ca 125 at 3 months and 6 months.

Timeline

Start
2020-07-01
Primary completion
2021-06-21
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cabergoline Small molecule 0.5 mg Oral
Comparator Dydrogesterone Other / unclassified 10 mg Oral